1. Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives

   • Mario Cazzola
   • Paola Rogliani
   • Maria Gabriella Matera

   Current Opinion 28 August 2015 Pages: 1575 - 1585

   

2. New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins

   • Margaret V. Ragni

   Leading Article 27 August 2015 Pages: 1587 - 1600

   

3. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics

   • Sophie Marchal
   • Amélie El Hor
   • Lina Bezdetnaya

   Review Article 01 September 2015 Pages: 1601 - 1611

   

4. Current Strategies to Reduce Gastrointestinal Bleeding Risk Associated with Antiplatelet Agents

   • Parth J. Parekh
   • Edward C. Oldfield IV
   • David A. Johnson

   Review Article 02 September 2015 Pages: 1613 - 1625

   

5. Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities

   • Paul P. Dobesh
   • John Fanikos

   Review Article Open access 14 September 2015 Pages: 1627 - 1644

6. Roflumilast: A Review in COPD

   • Karly P. Garnock-Jones

   Adis Drug Evaluation 04 September 2015 Pages: 1645 - 1656

   

7. Perampanel: A Review in Drug-Resistant Epilepsy

   • James E. Frampton

   Adis Drug Evaluation 14 September 2015 Pages: 1657 - 1668

   

8. Eliglustat: A Review in Gaucher Disease Type 1

   • Lesley J. Scott

   Adis Drug Evaluation 18 September 2015 Pages: 1669 - 1678

9. AFREZZA^® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus

   • Esther S. Kim
   • Greg L. Plosker

   Adis Drug Evaluation 18 September 2015 Pages: 1679 - 1686

   

10. Brexpiprazole: First Global Approval

    • Sarah L. Greig

    AdisInsight Report 27 August 2015 Pages: 1687 - 1697

    

11. Alirocumab: First Global Approval

    • Anthony Markham

    AdisInsight Report 14 September 2015 Pages: 1699 - 1705